Roche signs Dx development deal with Pacific Biosciences

09/26/2013 | American City Business Journals

Pacific Biosciences of California has struck a deal to develop and sell sequencing tools and consumables exclusively to Roche Diagnostics. Pacific Biosciences will receive $35 million in cash and potentially $40 million more from the deal, which also gives Roche exclusive rights to use the technologies for nucleic acid sequencing for in vitro diagnostics for humans.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ